{"id":385939,"date":"2022-07-01T00:00:00","date_gmt":"2022-07-01T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47031217-medtech-sports-medicine-devices-market-insights-asia-pacific-supplemental-2022\/"},"modified":"2026-05-12T11:05:35","modified_gmt":"2026-05-12T11:05:35","slug":"47031217-medtech-sports-medicine-devices-market-insights-asia-pacific-supplemental-2022","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47031217-medtech-sports-medicine-devices-market-insights-asia-pacific-supplemental-2022\/","title":{"rendered":"Sports Medicine Devices | Market Insights | Asia Pacific (Supplemental) | 2022"},"content":{"rendered":"<p>The Asia Pacific sports medicine device market has been significantly impacted by treatment deferrals due to the\u00a0COVID-19\u00a0pandemic, and the voluntary nature of many of the postponed surgeries may slow recovery to some extent. The ability of facilities to return to prepandemic capacity, as well as the rate at which vaccines are distributed, will determine the market&#8217;s recovery. Ultimately, beyond the impact of the\u00a0COVID-19\u00a0pandemic, this market will expand\u00a0significantly\u00a0throughout the forecast period due to continued growth in underpenetrated procedures, the launch of new products, and improved physician training. However, a lack of reimbursement, financial limitations, and the impact of the\u00a0COVID-19\u00a0pandemic will limit market growth to some extent.<\/p>\n<p>This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the sports medicine device market in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, from 2019 through 2030.<\/p>\n","protected":false},"template":"","class_list":["post-385939","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-sports-medicine-devices","medtech-geography-asia-pacific","medtech-date-967"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385939","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385939\/revisions"}],"predecessor-version":[{"id":387448,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385939\/revisions\/387448"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}